Skip to main content
. 2017 Dec 6;8(69):113303–113317. doi: 10.18632/oncotarget.22964

Figure 6. IL-1β and IL-18 neutralizing antibody effects on uremic toxin IS-induced early apoptosis and cell viability of H9c2 cells.

Figure 6

(A) Control. (B) Indoxyl sulfate (IS)-treated group. (C) IS- and IL-1β antibody-treated group. (D) IS- and IL-18 antibody-treated group. H9c2 cells were treated and stained for flow cytometry analysis. Lower right, early apoptosis rate of H9c2 cells. (E) MTT assay, showing the viability of IL-1β and IL-18 antibody-treated cells. All data are presented as mean ± SEM. ns=no significance.